Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for AEON Biopharma Inc in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
DI
Dauntless Investment Group, LLC
|
12.5M | 25.04% | +10.0M (+394.1%) | 2025 | 7.1% | |
|
Shares held by quarter
Peak holding12.5M (Q2'26)
Change over 8 quarters+12.5M
Share of the company25.040%
|
||||||
|
GC
Geode Capital Management, LLC
|
95.3K | 0.19% | +8.2K (+9.5%) | 2025 | 0.0% | |
|
Shares held by quarter
Peak holding251.8K (Q4'24)
Change over 8 quarters−147.9K
Share of the company0.190%
|
||||||
24 more super investors behind a free account
See every manager holding AEON Biopharma Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VE
Vanguard Index Funds
|
$65.1K | 90.5K | 0.18% | 0.00% | June 30, 2026 |
|
FE
Fidelity Concord Street Trust
|
$36K | 47.5K | 0.10% | 0.00% | May 31, 2026 |
2 more funds behind a free account
See every fund holding AEON Biopharma Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
RJ
Robert J Palmisano
5%+ holder
13D · 5.7%
|
2.3M | 4.54% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
D(
Daewoong Co.,Ltd. ("DWC")
5%+ holder
13D · 0.9%
|
91.4K | 0.18% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
Loading...
